A Randomized, Double-Blind, Single-Site Phase II 2-Arm Study to Compare the Safety and Preliminary Efficacy of Manualized MDMA-Assisted Therapy to Low Dose D-Amphetamine Assisted Therapy in Veterans For The Treatment of Moderate to Severe PTSD
Phase: PHASE2 | Sponsor: Stephen Robert Marder | Compound: MDMA
- Status
- recruiting
- Institution
- Stephen Robert Marder
- Start date
- 2025-03-01
- End date
- 2026-03-01
- Registry ID
- NCT05790239
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.